NCT00049686 2013-07-18VNP40101M in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic SyndromeNational Cancer Institute (NCI)Phase 1 Completed
NCT00004058 2010-01-2612-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow DisorderRutgers, The State University of New JerseyPhase 1 Terminated